Impact of hydroxyurea on pediatric sleep in sickle cell disease
Authors:
- Michelle YooMYMichelle Yoo
- Shasha BaiSBShasha Bai
- Grace KalmusGKGrace Kalmus
- Lindsey AbelLALindsey Abel
- Carlton DampierCDCarlton Dampier
- Michelle GillespieMGMichelle Gillespie
- Snehal ValaSVSnehal Vala
- Tracy HuangTHTracy Huang
- Kirshma KhemaniKKKirshma Khemani
- Roberta LeuRLRoberta Leu
- Benjamin T. KoppBKBenjamin T. Kopp
Open Access
- 17 September 2025
- journal article
- Published by Elsevier in Blood Red Cells & Iron
- Vol. 1 (3)
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell DiseasePediatric Blood & Cancer, 2025
- Updates in Pediatric Sickle Cell Lung DiseaseClinics in Chest Medicine, 2024
- Screening for Obstructive Sleep Apnea in Children With Sickle Cell Disease: A Pilot StudyThe Laryngoscope, 2020
- A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseNew England Journal of Medicine, 2019
- Sickle cell diseaseNature Reviews Disease Primers, 2018
- Comorbid obstructive sleep apnea and increased risk for sickle cell disease morbiditySleep and Breathing, 2018
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell DiseaseNew England Journal of Medicine, 2017
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)The Lancet, 2011
- Sickle Red Cell Microrheology and Sickle Blood RheologyMicrocirculation, 2004
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995